2022
DOI: 10.1097/tp.0000000000004201
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures

Abstract: Background. Biliary strictures frequently occur in living-donor liver transplant (LDLT) recipients. However, long-term clinical outcomes and their associated factors are unclear. Methods. We analyzed an historical cohort of 228 recipients who underwent LDLT with post-liver transplantation biliary strictures. Endoscopic retrograde cholangiography or percutaneous transhepatic biliary drainage were performed to treat biliary strictures. Patients that experienced persistent jaundice over 3 mo after the initial t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 46 publications
0
1
1
Order By: Relevance
“…In a study by Han et al 25 , the average time to diagnosis of biliary strictures after LDLT was 4.2 months, whereas in our study it was approximately 3.5 months. These results suggest that BCs after LDLT are more common in the first 6 months postoperatively.…”
Section: Discussioncontrasting
confidence: 80%
“…In a study by Han et al 25 , the average time to diagnosis of biliary strictures after LDLT was 4.2 months, whereas in our study it was approximately 3.5 months. These results suggest that BCs after LDLT are more common in the first 6 months postoperatively.…”
Section: Discussioncontrasting
confidence: 80%
“…Anastomotic biliary strictures post liver transplantation (LT) represent a particular category of benign biliary strictures, impacting the survival of both graft and patient [ 1 ]. They are primarily diagnosed within 12 months post-transplantation with a prevalence of 6.6-35.5%, associated with recurrent cholangitis, transplant failure or rejection, prolonged admissions, graft survival reduction, portal hypertension, re-transplantation, and a healthcare and cost burden [ 1 - 4 ].…”
Section: Introductionmentioning
confidence: 99%